{"url_path":"/fda/drug/recalls/D-0723-2026","section_key":"summary","section_title":"DRUG Recall: Lupin Pharmaceuticals Inc. — Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-06-23","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0723-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Lupin Pharmaceuticals Inc."},"word_count":123,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0723-2026\n\n**Recalling firm:** Lupin Pharmaceuticals Inc.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-06-23\n**Report date:** 2026-07-08\n\n## Product\nGlucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01\n\n## Reason\nCGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.\n\n## Affected lots\nKit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.\n\n## Distribution\nNationwide within the U.S."}